A convenience sample of 20 elevated risk WISDOM Study participants was identified in the personalized arm without a breast cancer mutation (namely BRCA1, BCRA2, TP53, PTEN, STK11, CDH1, ATM, PALB2, CHEK2). Here, PALB2 is linked to breast carcinoma.